{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:30:40Z","timestamp":1792697440245,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood disorder, \u03b2-thalassaemia, is considered an attractive target for gene correction. Site-specific triplex formation has been shown to induce DNA repair and thereby catalyse genome editing. Here we report that triplex-forming peptide nucleic acids (PNAs) substituted at the \u03b3 position plus stimulation of the stem cell factor (SCF)\/c-Kit pathway yielded high levels of gene editing in haematopoietic stem cells (HSCs) in a mouse model of human \u03b2-thalassaemia. Injection of thalassemic mice with SCF plus nanoparticles containing \u03b3PNAs and donor DNAs ameliorated the disease phenotype, with sustained elevation of blood haemoglobin levels into the normal range, reduced reticulocytosis, reversal of splenomegaly and up to 7% \u03b2-globin gene correction in HSCs, with extremely low off-target effects. The combination of nanoparticle delivery, next generation \u03b3PNAs and SCF treatment may offer a minimally invasive treatment for genetic disorders of the blood that can be achieved safely and simply by intravenous administration.<\/jats:p>","DOI":"10.1038\/ncomms13304","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T07:19:06Z","timestamp":1477466346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["In vivo correction of anaemia in \u03b2-thalassemic mice by \u03b3PNA-mediated gene editing with nanoparticle delivery"],"prefix":"10.1038","volume":"7","author":[{"given":"Raman","family":"Bahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ali McNeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parker","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Turchick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh C.","family":"Bhunia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale L.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"L\u00f3pez-Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Beloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane S.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios T.","family":"Braddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mark Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danith H.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"BFncomms13304_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/156652311794520120","volume":"11","author":"E-M Haendel","year":"2011","unstructured":"Haendel, E.-M. & Cathomen, T. Zinc-finger nuclease based genome surgery: it\u2019s all about specificity. Curr. Gene Ther. 11, 28\u201337 (2011).","journal-title":"Curr. Gene Ther."},{"key":"BFncomms13304_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms13304_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/oli.2006.16.213","volume":"16","author":"KK Goncz","year":"2006","unstructured":"Goncz, K. K. et al. Small fragment homologous replacement-mediated modification of genomic beta-globin sequences in human hematopoietic stem\/progenitor cells. Oligonucleotides 16, 213\u2013224 (2006).","journal-title":"Oligonucleotides"},{"key":"BFncomms13304_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1126\/science.290.5491.530","volume":"290","author":"KM Vasquez","year":"2000","unstructured":"Vasquez, K. M., Narayanan, L. & Glazer, P. M. Specific mutations induced by triplex-forming oligonucleotides in mice. Science 290, 530\u2013533 (2000).","journal-title":"Science"},{"key":"BFncomms13304_CR5","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).","journal-title":"Science"},{"key":"BFncomms13304_CR6","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1093\/nar\/gkt714","volume":"41","author":"TJ Cradick","year":"2013","unstructured":"Cradick, T. J., Fine, E. J., Antico, C. J. & Bao, G. CRISPR\/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41, 9584\u20139592 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms13304_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/365566a0","volume":"365","author":"M Egholm","year":"1993","unstructured":"Egholm, M. et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (London) 365, 566\u2013568 (1993).","journal-title":"Nature (London)"},{"key":"BFncomms13304_CR8","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1962210","volume":"254","author":"PE Nielsen","year":"1991","unstructured":"Nielsen, P. E., Egholm, M., Berg, R. H. & Buchardt, O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254, 1497\u20131500 (1991).","journal-title":"Science"},{"key":"BFncomms13304_CR9","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1073\/pnas.95.4.1398","volume":"95","author":"AF Faruqi","year":"1998","unstructured":"Faruqi, A. F., Egholm, M. & Glazer, P. M. Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells. Proc. Natl Acad. Sci. USA 95, 1398\u20131403 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms13304_CR10","doi-asserted-by":"publisher","first-page":"16695","DOI":"10.1073\/pnas.262556899","volume":"99","author":"FA Rogers","year":"2002","unstructured":"Rogers, F. A., Vasquez, K. M., Egholm, M. & Glazer, P. M. Site-directed recombination via bifunctional PNA-DNA conjugates. Proc. Natl Acad. Sci. USA 99, 16695\u201316700 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms13304_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/mc.20501","volume":"48","author":"JY Chin","year":"2009","unstructured":"Chin, J. Y. & Glazer, P. M. Repair of DNA lesions associated with triplex-forming oligonucleotides. Mol. Carcinog. 48, 389\u2013399 (2009).","journal-title":"Mol. Carcinog."},{"key":"BFncomms13304_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/gt.2012.82","volume":"20","author":"NA McNeer","year":"2013","unstructured":"McNeer, N. A. et al. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther. 20, 658\u2013669 (2013).","journal-title":"Gene Ther."},{"key":"BFncomms13304_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.chembiol.2011.07.010","volume":"18","author":"EB Schleifman","year":"2011","unstructured":"Schleifman, E. B. et al. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem. Biol. 18, 1189\u20131198 (2011).","journal-title":"Chem. Biol."},{"key":"BFncomms13304_CR14","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/mtna.2013.59","volume":"2","author":"EB Schleifman","year":"2013","unstructured":"Schleifman, E. B. et al. Site-specific genome editing in PBMCs With PLGA nanoparticle-delivered PNAs confers HIV-1 resistance in humanized mice. Mol. Ther. Nucleic Acids 2, e135 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"BFncomms13304_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2174\/1566523214666140825154158","volume":"14","author":"R Bahal","year":"2014","unstructured":"Bahal, R. et al. Single-stranded \u03b3PNAs for in vivo site-specific genome editing via watson-crick recognition. Curr. Gene Ther. 14, 331\u2013342 (2014).","journal-title":"Curr. Gene Ther."},{"key":"BFncomms13304_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/cbic.201100646","volume":"13","author":"R Bahal","year":"2012","unstructured":"Bahal, R., Sahu, B., Rapireddy, S., Lee, C.-M. & Ly, D. H. Sequence-unrestricted, watson-crick recognition of double helical B-DNA by (R)-miniPEG-\u03b3PNAs. ChemBioChem 13, 56\u201360 (2012).","journal-title":"ChemBioChem"},{"key":"BFncomms13304_CR17","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.V91.6.2152","volume":"91","author":"J Lewis","year":"1998","unstructured":"Lewis, J. et al. A common human beta globin splicing mutation modeled in mice. Blood 91, 2152\u20132156 (1998).","journal-title":"Blood"},{"key":"BFncomms13304_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1073\/pnas.0812436106","volume":"106","author":"S Svasti","year":"2009","unstructured":"Svasti, S. et al. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice. Proc. Natl Acad. Sci. USA 106, 1205\u20131210 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms13304_CR19","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nbt759","volume":"20","author":"P Sazani","year":"2002","unstructured":"Sazani, P. et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20, 1228\u20131233 (2002).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms13304_CR20","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1021\/jo200482d","volume":"76","author":"B Sahu","year":"2011","unstructured":"Sahu, B. et al. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing \u03b3-peptide nucleic acids with superior hybridization properties and water solubility. J. Org. Chem. 76, 5614\u20135627 (2011).","journal-title":"J. Org. Chem."},{"key":"BFncomms13304_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/mt.2010.200","volume":"19","author":"NA McNeer","year":"2011","unstructured":"McNeer, N. A. et al. Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Mol. Ther. 19, 172\u2013180 (2011).","journal-title":"Mol. Ther."},{"key":"BFncomms13304_CR22","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo, L. J. & Yang, L. X. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 22, 305\u2013309 (2008).","journal-title":"In Vivo"},{"key":"BFncomms13304_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.stem.2007.07.005","volume":"1","author":"CJ Pronk","year":"2007","unstructured":"Pronk, C. J. et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 1, 428\u2013442 (2007).","journal-title":"Cell Stem Cell"},{"key":"BFncomms13304_CR24","doi-asserted-by":"publisher","first-page":"12065","DOI":"10.1038\/srep12065","volume":"5","author":"P Xu","year":"2015","unstructured":"Xu, P. et al. Both TALENs and CRISPR\/Cas9 directly target the HBB IVS2-654 (C&gt;T) mutation in beta-thalassemia-derived iPSCs. Sci Rep. 5, 12065 (2015).","journal-title":"Sci Rep."},{"key":"BFncomms13304_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/scd.2014.0347","volume":"24","author":"B Song","year":"2015","unstructured":"Song, B. et al. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR\/Cas9 system. Stem Cells Dev. 24, 1053\u20131065 (2015).","journal-title":"Stem Cells Dev."},{"key":"BFncomms13304_CR26","doi-asserted-by":"publisher","first-page":"18018","DOI":"10.1074\/jbc.M011646200","volume":"276","author":"HJ Datta","year":"2001","unstructured":"Datta, H. J., Chan, P. P., Vasquez, K. M., Gupta, R. C. & Glazer, P. M. Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J. Biol. Chem. 276, 18018\u201318023 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFncomms13304_CR27","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1073\/pnas.082193799","volume":"99","author":"KM Vasquez","year":"2002","unstructured":"Vasquez, K. M., Christensen, J., Li, L., Finch, R. A. & Glazer, P. M. Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc. Natl Acad. Sci. USA 99, 5848\u20135853 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms13304_CR28","first-page":"75","volume":"7","author":"M Andreani","year":"1991","unstructured":"Andreani, M. et al. Persistence of mixed chimerism in class 3 thalassemic patients following BMT. Bone Marrow Transplant. 7, (Suppl 2): 75 (1991).","journal-title":"Bone Marrow Transplant."},{"key":"BFncomms13304_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/sj.mt.6300204","volume":"15","author":"H Felfly","year":"2007","unstructured":"Felfly, H. & Trudel, M. Long-term correction of beta-thalassemia with minimal cellular requirement and transplantation modalities. Mol. Ther. 15, 1701\u20131709 (2007).","journal-title":"Mol. Ther."},{"key":"BFncomms13304_CR30","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1073\/pnas.0711666105","volume":"105","author":"A Miccio","year":"2008","unstructured":"Miccio, A. et al. In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia. Proc. Natl Acad. Sci. USA 105, 10547\u201310552 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms13304_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/adhm.201400355","volume":"4","author":"RJ Fields","year":"2015","unstructured":"Fields, R. J. et al. Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Adv. Healthcare Mater. 4, 361\u2013366 (2015).","journal-title":"Adv. Healthcare Mater."},{"key":"BFncomms13304_CR32","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1038\/ncomms7952","volume":"6","author":"NA McNeer","year":"2015","unstructured":"McNeer, N. A. et al. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nat. Commun. 6, 6952 (2015).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms13304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms13304","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms13304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T04:46:00Z","timestamp":1672807560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms13304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFncomms13304"],"URL":"https:\/\/doi.org\/10.1038\/ncomms13304","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726887835.793527598","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]},"assertion":[{"value":"14 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.M.S., P.M.G., R.B., N.A.M. and D.H.L. are inventors on a related patent application. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13304"}}